Work

Supplementary Figure S2 from Immunologic Profiling of Immune-Related Cutaneous Adverse Events with Checkpoint Inhibitors Reveals Polarized Actionable Pathways

Year: 2024
Type: supplementary-materials
Abstract: Supplementary Figure S2. Peripheral blood differential cell counts assessment of patients with cancer experiencing checkpoint inhibitor induced immune-related cutaneous adverse events (ircAE).
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: gold
OpenAlex ID: W4400215271
Cites:
Cited by:
Related to: 10